InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,274.45
(
0.05%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: intune post# 2892

Tuesday, 10/26/2010 1:08:33 PM

Tuesday, October 26, 2010 1:08:33 PM

Post# of 80490
More importantly, all this talk about Ariad going into "front-line".

How are they going to do a head-to-head trial with Tasigna et al without 50/50 or 100% of funding from a partner? There is NO WAY this financing gets them through their current Phase 2/3 trial in CML and other cancers ***AND*** a massive front-line comparator trial.

So, when's the next dilution from The Harv?



Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up